Search PDMR transactions

Notifier
Name of person with notification obligation
Magnus Olafsson Corfitzen
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Magnus Olafsson Corfitzen
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Ascelia Pharma AB
Issuer´s LEI code
5493002YR9VCJJPWYN08
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Ascelia Pharma AB SE0010573113 Acquisition 40,000 Quantity 4.179116 SEK 05/01/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Ascelia Pharma AB SE0010573113 Acquisition 05/01/2024 NASDAQ STOCKHOLM AB 40,000 (Quantity) 4.179116 SEK
Total: 40,000
<< Back